Lonza, which is dealing with FDA concerns about its cell manufacturing facility in the U.S., has acquired a gene and cell CMO in Europe.

Roche has recalled all of its 5-mg Valium blister packs in Australia after uncovering a supply chain breach at a distributor's warehouse.

Russia-based NovaMedica has started work on a new plant where it will produce 30 Pfizer sterile injected generic meds for the local market.

The FDA has brought its regulatory hammer down on a B. Braun plant in California that makes parenteral drugs, saying managers let problems go on for more than…

A month after Daiichi Sankyo announced plans for a major investment in cancer drug production, Japanese compatriot Otsuka said it is planning to do the same…

Sun Pharma has suffered a gut-wrenching drop in its sales in the U.S. as ongoing regulatory restraints for Sun Pharma’s key API plant in India, along with…

GlaxoSmithKline has added three more lots of its Ventolin inhalers to its recent recall, bringing the total to more than 1.1 million units.

Johnson & Johnson is putting behind it the lingering legal problems that stemmed from manufacturing issues that led to recalls some years back.

Supply Chain